🗓️ July 2024 - June 2030 

💰  €10.000.000 

🔗Site

Colorectal cancer (CRC) represents a significant proportion of malignant diseases. Interventions are often carried out during the latter stages of development, leading to low patient survival rates and poor quality of life. In 2022 a European Commission report stated that “colonoscopy-based screening has higher sensitivity than testing for blood in stool, but it is less acceptable to participants”. At the same time, effective methods to treat polyps in the colon are limited. Current approaches are often associated with unsafe oncological margins and high complication rates, requiring life-changing surgery. EndoTheranostics will usher in a new era for screening colonoscopy, advancing the frontiers of medical imaging and robotics. A tip- growing or eversion robot with a sleeve-like structure will be created to extend deep into hollow spaces while perceiving the environment through multimodal imaging and sensing. It will also act as a conduit to transfer miniaturised instruments to the remote site within the colon for diagnosis and therapy (theranostics). With these capabilities, the system will be able to offer:

1. painless colon cleansing in preparation for endoscopy;

2. real-time polyp detection and tissue characterisation through AI-assisted multimodal imaging;

3. effective removal of polyps by conveying a “miniature mobile operating chamber” equipped with microsurgical tools to the target through the lumen of the eversion robot.

The unique technical and clinical challenges will be tackled by the PIs, each bringing complementary skills, backed by their institutions with wide expertise and exceptional facilities. The synergy and added value evident in this team will lead to breakthroughs not possible through independent research. The outcomes of EndoTheranostics will revolutionise the theranostics of CRC, impacting the quality of life of millions of individuals. Ultimately it will launch a new era for endoluminal intervention with applications beyond medicine.

🗓️ January 2023 - December 2025 

🔗Site 

💰  €12.553.947,5

Population ageing is a global phenomenon reshaping societies, markets, and welfare systems, especially in high-income countries. In Italy, with one of the highest life expectancies in the world, ageing represents both a challenge and an opportunity to enhance well-being and social sustainability.

Age-It aims to position Italy as a leader in ageing research, overcoming barriers such as data fragmentation and lack of interdisciplinary collaboration. Through a holistic, collaborative approach, Age-It brings together universities, institutions, businesses, and public and private entities to create innovative solutions that promote healthy, inclusive ageing.

The key objectives are:

1. Defining Research Standards: Establish an interdisciplinary framework for global ageing research.

2. Promoting Innovation: Create sustainable technological solutions, fostering start-ups and spin-offs.

3. Reforming Welfare: Develop policies to reduce inequalities and promote equitable ageing.

4. Training New Generations: Educate interdisciplinary researchers, focusing on disadvantaged regions.

5. Connecting Academia and Industry: Accelerate the translation of research into practical solutions.

Age-It’s transdisciplinary approach spans fields such as geriatrics, data science, engineering, sociology, and economics, creating a unique platform to pioneer new methodologies and solutions. From advancing the Silver Economy to redefining care models and public policies, Age-It aims to transform ageing into a cornerstone of economic, social, and environmental progress. 

🗓️ November 2023 - October 2025 

💰  €240.286,00

Surgical techniques have been significantly changed by robotics. Enhanced dexterity, ergonomics, motion scaling, and tremor filtering are some of the improvements over traditional laparoscopy. The surgeon must acquire sufficient knowledge and abilities in order to use the robot safely and effectively, and novice surgeons always receive intensive training in virtual and simulated environments. Surgeons' proctoring (a proctor is an instructor who is responsible for the actions of other surgeons) allows hospitals to maintain standardized surgical treatment quality across several sites. Severe issues may occur due to the extremely dynamic and safety-critical environment. By directing the leading surgeon toward the most effective intervention, surgical proctoring enables sustaining high-quality intervention, intervening physically or verbally in crucial moments. However, certified expert proctors are becoming extremely limited in opposition to the demand for high-quality robotic surgical training. For these reasons, an intelligent robotic system could provide great benefits in proctoring and surgical training. Additionally, advanced computer vision algorithms and novel control techniques incorporate components that lessen the physical and mental stress on the surgeon and improve the efficiency of surgical procedures. This research intends to provide effective approaches that allow the robot to gain expert cognitive and procedural surgical abilities while assisting surgeons throughout procedures, similarly to an experienced proctor. Surgeon's body measures, such as: kinetic movements of upper limbs, cardiac electrical activity, muscular electrical activity, breathing activity, electrodermal activity, as well as surgical site information (extracted from endoscopic images) represent powerful tools to identify and quantify surgeon skills and proctor functions in order to develop novel training technologies and advanced assistive robot control overcoming the teleoperation paradigm. Advanced wearable sensor technology and motion capture cameras, will be utilized to monitor the physical states of the proctors and surgeons. Three distinct surgeon categories will be explored, each categorized according to their level of expertise (expert, intermediate, and novice). Data will be collected during ordinary surgical operations and tutoring sessions using the da Vinci Xi. The developed innovative assistive technologies will be tested on the da Vinci Research Kit and simulation environments. Data analysis will yield quantitative indices, with the key parameters being the execution time and intervention quality. Artificial Intelligence techniques will be utilized to process the acquired data and establish a reference set, allowing the robotic system to learn where, when, and how to act like an expert surgeon. As a result, the robot can react and support the surgeon in real-time by employing verbal and acoustic signals and advanced assistive control strategies. 

🗓️ September 2023 - August 2025 

💰  €141.402,00

Digestive tract cancers make up a significant proportion of malignant diseases. Interventions are often carried out during the latter stages of development, leading to low patient survival rates and poor quality of life. Among these, colorectal cancer (CRC) remains a killer as people tend to avoid colonoscopy screening programs that are often perceived as painful and uncomfortable. Effective methods to treat dysplastic polyps in the colon are limited and current approaches are often associated with unsafe oncological margins and high complication rates, often requiring life-changing surgery. TI-RED will usher in a new era for screening colonoscopy, advancing the frontiers of robotic surgery and medical imaging research. A miniaturized surgical robot will be created to be fixed at the tip of a small endoscope so that it can extend deep into hollow spaces whilst perceiving the environment through multimodal imaging and sensing. With these capabilities, the system will be able to offer: a. real-time tissue characterisation through AI-assisted multi-spectral imaging and ultrasound; b. the effective removal of polyps using a ‘miniature operating chamber’ equipped with microsurgical tools c. supervised automatic polyp dissection by deep learning methods for object recognition and segmentation. TI-RED will advance science in the fields of microsurgical robotics, focusing on the unmet clinical needs of a socially relevant disease: colorectal cancer (CRC). TI-RED will push the boundaries of minimally invasive robotic surgery beyond the state-of-the-art, solutions to perceiving and interacting with the environment for robots while operating within otherwise inaccessible spaces. TI-RED aims to obviate the need for major surgery and reduce mortality rates. The synergy and added value evident in this team and in the partners will lead to breakthroughs. TI-RED will revolutionise CRC treatment, positively impacting the quality of life for about 2 million individuals/year worldwide. 

🗓️ September 2023 - August 2025 

💰  €204.471,00

With aging, many biological processes influencing the musculoskeletal system strongly affect peoples’ strength and endurance capacities, as well as abilities in coordination, stability, and balance. Therefore, gait disorders and lower-limb impairments are common and often devastating companions of aging, limiting people’s independence in daily activities. Although the relationship between age and physiological and physical functions is very complex, it has been widely shown that physical abilities are generally superior in physically active people. Inspired by the concept of “prehabilitation”, this project aims to promote active lifestyles based on regular moderate-intensity physical training that could help elderly people limit the gradual decay of physical functions due to aging, through lightweight and portable wearable robots. More specifically, this project aims to design and validate completely novel paradigms of enhanced gait training programs based on robotic exoskeletons with high-fidelity impedance performance, that could provide adaptive training programs in functional tasks. This project opens new chances to apply wearable robots in the field of “active aging”, which represents a new application domain for wearable robots, traditionally investigated in other fields, e.g., rehabilitation, assistance, and occupational sectors. 

🗓️ December 2022 - June 2026 

💰  €13.163.926,00

🔗Site 

Fit4MedRob aims to revolutionize current rehabilitation and assistive models for people with reduced or absent sensory or cognitive motor functions. We will develop new (bio)robotic and digital technologies and continuum of care paradigms that can benefit from new technologies in all phases of the rehabilitation process, from prevention to home assistance in the chronic phase. This will be possible by carefully identifying the unmet needs of patients and healthcare professionals. Such needs will be addressed with current and new (bio)robotic/bionic technologies, through multi-centre clinical studies jointly designed by bioengineers, neuroscientists, physiatrists, psychologists and functional specialists/preventive surgeons of arts. Fit4MedRob will focus on both already available technologies that have not yet been fully validated, and emerging technologies or breakthrough ideas to be explored in the course of the project. Fundamental studies, involving new materials, algorithms, smart sensing and actuation technologies, and sustainable energy sources, will try to overcome the limitations of current robotic solutions, which have prevented their massive diffusion as providers of physical assistance. The ambitious goal of the project is to pave the way for the next generation of biomedical robotic systems. Last but not least, clinical, scientific and technological efforts will be matched on the political, regulatory and organizational side to accelerate the creation of an adequate framework to (sustainably) incorporate current and future technologies and protocols into the healthcare system while supporting the innovation they will bring.

🗓️ October 2022 - September 2025 

💰  €4.753.057,00

The project aims to enhance the research infrastructures on surgical robotics and to create a new infrastructure for biorobotics thanks to the creation of a new laboratory: Biomimetic and Biohybrid Robotics Lab (B2RL). B2RL will provide a framework for the design and fabrication of prosthetics and exoskeletons as biological interfaces for communicating with the human body. This includes the adoption and composition of biohybrid and biomimetic materials and design methods, biocompatible actuators and sensors, and the development of appropriate shared human-machine control strategies. 

🗓️  January 2021 - June 2024 

💰  €7.191.613,75

🔗Site 

HARMONY develops robotic mobile manipulation technologies for assisting staff in hospital environments. Europe’s ageing population along with higher numbers of people in the healthcare system will require increased care and staffing levels. Automation will become a quality and precision must and a medical business fact. However, the reality is that our current robotic automation solutions only offer “islands of automation” where either mobility or manipulation is dealt with in isolation. The project aims to fill this gap in knowledge on combining both robotic mobility and manipulation modalities in complex, human-centred environments. Through demonstrators and open software modules, robotic mobile manipulation systems can be seamlessly integrated into our existing processes and spaces to meet growing needs in the healthcare industry and beyond.  

🗓️   October 2018 - February 2021 

💰  €3.148.453,00

Prostate cancer is the most frequent malignant neoplasm and the second cause of cancer death among men, with a steady increase in trend due to the overall length of life expectancy. Despite the technological progress of radiological instrumental investigation and the ultrasound systems needed to perform the biopsy, a false negative rate remains that swings around 30%. This project aims at effectively increasing the diagnostic capacity of prostate biopsy. To achieve this goal, an advanced biopsy robotic system is developed for high-precision testing and integration of an autonomous control, an optical fiber probe, an image fusion software, and a predictive software for detecting prostate cancer and its aggressiveness. The expected improvements concern a reduction of: the number of prostate tissue samples, the number of biopsies for the patient, the risk of complications associated with biopsy, the direct and indirect costs of healthcare expenditure to diagnose prostate cancer. 

🗓️   April 2018 - October 2021 

💰  €8.754.244,00

Prostate cancer (PCa) is the most frequent malignancy in men, with a worldwide incidence of 60-99 new cases/100,000 a year. In Italy, PCa represents 18% of male cancers and accounts for 8% of mortality. The aim of this project is to design and develop new medical devices to improve our ability to diagnose and cure PCa. First, we want to generate a high-precision device for prostate cancer biopsy, based on the implementation of a robotic arm allowing targeted bioptic sampling based on the information gained from magnetic resonance and ultrasound images. Second, we want to develop an advanced prototype for treatment of PCa, exploiting the selective effects of micro-mechanical vibration stress on tumor cells, thus killing them while sparing neighbour healthy cells. The robotic system for prostate-guided needle biopsy is conceived as a system capable of self-learning through the storage and processing of maps derived from prostatic imaging. 

🗓️   February 2017 - January 2019 

💰  €95.000,00

🔗Site 

MUSHA aims at creating future generations of bio-inspired tools and advanced bio-aware manipulation paradigms toward breakthrough mini-invasive surgical instruments and android robotic hands. Bio-inspired mechanical design leads to reduction of tools’ weight and dimension by limiting the number of actuators while preserving dexterity and manipulation capabilities. A fiber optic sensor is to be integrated to measure the contact forces exchanged with the environment and the temperature of the touched materials. MUSHA arises from the need to replicate human manipulation capabilities in various fields where robotics can help to improve life. These include unstructured environments in which a humanoid robot must replace the human being or parts of the body to address daily-life tasks, as well as minimally invasive robotic surgery where the surgeon is unable to use hands to manipulate organs and tissues while feeling their anatomy, consistency and temperature.